Edition:
India

Adverum Biotechnologies Inc (ADVM.OQ)

ADVM.OQ on NASDAQ Stock Exchange Global Market

22.67USD
5 Jun 2020
Change (% chg)

$2.39 (+11.82%)
Prev Close
$20.27
Open
$20.67
Day's High
$22.68
Day's Low
$20.28
Volume
378,243
Avg. Vol
511,904
52-wk High
$23.77
52-wk Low
$4.96

Select another date:

Fri, May 29 2020

BRIEF-Adverum Biotech Announces New Mid-Stage Trial For ADVM-022 In Diabetic Macular Edema

* ADVERUM BIOTECHNOLOGIES ANNOUNCES NEW INFINITY PHASE 2 TRIAL FOR ADVM-022 IN DIABETIC MACULAR EDEMA, REPORTS RECENT BUSINESS PROGRESS AND FIRST QUARTER 2020 FINANCIAL RESULTS

BRIEF-Adverum Biotech Reports Positive Interim Data From Cohorts 1-3 Of Optic Phase 1 Trial Of Advm-022 Intravitreal Gene Therapy For Wet AMD

* ADVERUM BIOTECHNOLOGIES REPORTS POSITIVE INTERIM DATA FROM COHORTS 1-3 OF OPTIC PHASE 1 TRIAL OF ADVM-022 INTRAVITREAL GENE THERAPY FOR WET AMD

BRIEF-Adverum Biotechnologies Doses First Patient In Cohort 4 Of OPTIC Phase 1 Clinical Trial Of ADVM-022

* ADVERUM BIOTECHNOLOGIES DOSES FIRST PATIENT IN COHORT 4 OF OPTIC PHASE 1 CLINICAL TRIAL OF ADVM-022 INTRAVITREAL GENE THERAPY FOR WET AMD Source text for Eikon: Further company coverage:

BRIEF-Adverum Biotechnologies On April 16, Increased Size Of Board To Ten Members

* ADVERUM BIOTECHNOLOGIES INC - ON APRIL 16, INCREASED SIZE OF BOARD TO TEN MEMBERS Source text: [https://bit.ly/2wSTG7V] Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-Adverum Biotechnologies Reports Q4 Loss Per Share $0.29

* ADVERUM BIOTECHNOLOGIES REPORTS RECENT BUSINESS PROGRESS AND FOURTH QUARTER 2019 FINANCIAL RESULTS

BRIEF-Adverum Biotechnologies Announces $100 Mln Public Offering Of Common Stock

* ADVERUM BIOTECHNOLOGIES ANNOUNCES $100 MILLION PUBLIC OFFERING OF COMMON STOCK

BRIEF-Adverum Biotechnologies Reports New Interim Data From Cohorts 1 & 2 Of Optic Phase 1 Trial Of ADVM-022

* ADVERUM BIOTECHNOLOGIES REPORTS NEW INTERIM DATA FROM COHORTS 1 AND 2 OF OPTIC PHASE 1 TRIAL OF ADVM-022 INTRAVITREAL GENE THERAPY FOR WET AMD AT ANGIOGENESIS, EXUDATION, AND DEGENERATION 2020

Select another date: